Literature DB >> 27993583

Depression in Individuals With Traumatic and Nontraumatic Spinal Cord Injury Living in the Community.

Joan Saurí1, Andrés Chamarro2, Anna Gilabert3, Mariona Gifre3, Neus Rodriguez3, Raquel Lopez-Blazquez3, Lluïsa Curcoll3, Jesús Benito-Penalva3, Dolors Soler3.   

Abstract

OBJECTIVE: To assess depression in a sample of individuals with spinal cord injury (SCI) living in the community, and to determine the prevalence of probable major depressive disorder (PMDD) among those with traumatic spinal cord injury (T-SCI) and those with nontraumatic spinal cord injury (NT-SCI).
DESIGN: Cross-sectional.
SETTING: Data were collected on individuals with SCI now living in the community, who completed a comprehensive follow-up assessment at the hospital. PARTICIPANTS: Individuals with T-SCI or NT-SCI (N=831) completed the Patient Health Questionnaire-9 (PHQ-9) and were included.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: The PHQ-9 was used to detect the presence of PMDD and to measure the severity of the depression.
RESULTS: The most frequent etiology of SCI was T-SCI (66.9%). Overall, 16.2% of participants met the criteria for PMDD; however, a higher prevalence was noted for individuals with NT-SCI (21.1%) than for individuals with T-SCI (13.8%). Risk factors between T-SCI and NT-SCI did not differ greatly. Female sex, chronic pain, and lower levels of/difficulties in participation were associated with the presence of PMDD.
CONCLUSIONS: PMDD appears to occur at a higher rate in individuals with NT-SCI, with greater symptom severity. The finding that problems with participation are directly associated with depression raises the need for specific treatment goals, with the aim of empowering individuals with SCI to reintegrate into the community. Potential stress factors (eg, environmental barriers, limited participation options) should be addressed accordingly.
Copyright © 2016 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Rehabilitation; Spinal cord injuries

Mesh:

Year:  2016        PMID: 27993583     DOI: 10.1016/j.apmr.2016.11.011

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  6 in total

1.  Diagnostic accuracy and feasibility of depression screening in spinal cord injury: A systematic review.

Authors:  Rebecca Titman; Jason Liang; B Catharine Craven
Journal:  J Spinal Cord Med       Date:  2019-10       Impact factor: 1.985

2.  A multimodality intervention to improve musculoskeletal health, function, metabolism, and well-being in spinal cord injury: study protocol for the FIT-SCI randomized controlled trial.

Authors:  K F Reid; T W Storer; K M Pencina; R Valderrabano; N K Latham; L Wilson; C Ghattas; R Dixon; A Nunes; N Bajdek; G Huang; S E Skeels; A P Lin; S M Merugumala; H J Liao; M L Bouxsein; R D Zafonte; S Bhasin
Journal:  BMC Musculoskelet Disord       Date:  2022-05-25       Impact factor: 2.562

3.  Associations Between Doing Planned Exercise and Probable Major Depressive Disorder in Individuals Following Spinal Cord Injury.

Authors:  Catherine Jefferson VanDerwerker; Yue Cao; Chris M Gregory; James S Krause
Journal:  Top Spinal Cord Inj Rehabil       Date:  2020

Review 4.  Dementia, Depression, and Associated Brain Inflammatory Mechanisms after Spinal Cord Injury.

Authors:  Yun Li; Tuoxin Cao; Rodney M Ritzel; Junyun He; Alan I Faden; Junfang Wu
Journal:  Cells       Date:  2020-06-08       Impact factor: 6.600

5.  Identification of Mood and Body Mass Index as Modifiable Factors for Health Improvement in Spinal Cord Injury.

Authors:  Ruby Aikat; Varsha Singh
Journal:  Arch Rehabil Res Clin Transl       Date:  2021-12-09

6.  The impact of COVID-19 on community integration, quality of life, depression and anxiety in people with chronic spinal cord injury.

Authors:  Alejandro García-Rudolph; Joan Saurí; Jaume López Carballo; Blanca Cegarra; Mark Andrew Wright; Eloy Opisso; Josep María Tormos
Journal:  J Spinal Cord Med       Date:  2021-06-01       Impact factor: 2.040

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.